Orion Biotech Opportunities Corp (ORIA) Stock
ORIA is no longer traded. Orion Biotech Opportunities was delisted from the Nasdaq in May 2023.
Prices on this page are historical; the last trade was May 2, 2023 at $10.23.
Orion Biotech Opportunities stock price history
ORIA final trading statistics
- Final close
- $10.23
- Final trading day
- May 2, 2023
- Market cap at delisting
- $204.60M
- Shares outstanding
- 20.00M
- Final 52-week range
- $9.71 – $12.00
- Avg. volume (final 3 mo.)
- 70,613
- All-time high (split-adj.)
- $12.00 · May 2023
- All-time low (split-adj.)
- $9.58 · Aug 2021
- Return since IPO
- +6.6%
- Beta
- —
- Book value / share
- -$0.31
- Price / book
- -32.79
Orion Biotech Opportunities annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $0.00 | $18.4M | $0.35 |
| FY2021 | — | -$820.8K | -$0.03 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Orion Biotech Opportunities Corp
Orion Biotech Opportunities Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to acquire businesses in the biotechnology and life sciences sectors. Orion Biotech Opportunities Corp. was incorporated in 2021 and is based in New York, New York.
Orion Biotech Opportunities stock FAQ
What happened to Orion Biotech Opportunities stock?
Orion Biotech Opportunities stock was delisted from the Nasdaq. Its final close was $10.23 on May 2, 2023.
Is ORIA stock still trading?
No. ORIA was delisted from the Nasdaq in May 2023 and no longer trades on a U.S. exchange.
What was the last price of ORIA stock?
ORIA closed at $10.23 on its final trading day, May 2, 2023, for a market value of about $204.60M.
What were Orion Biotech Opportunities's revenue and earnings in its last full fiscal year?
Orion Biotech Opportunities reported revenue of $0.00 and net income of $18.4M in fiscal 2022, its last full year as a public company.
When did Orion Biotech Opportunities go public?
Orion Biotech Opportunities Corp stock began trading on July 13, 2021.